NEOsphere Biotechnologies
Expertise Partner
NEOsphere Biotechnologies pioneers proteomics for TPD drug discovery. Our target and E3 ligase-agnostic high-throughput proteomic screening platform creates broad pipelines of novel degrader targets at scale and advances drug discovery at all stages. Cutting-edge mass spectrometry and expert data analysis characterize entire libraries of protein degraders in native cells and identify molecules acting through new E3 ligases and TPD mechanisms; global ubiquitinomics mechanistically validates degrader-induced modifications to an unparalleled depth.
Promega
Expertise Partner
Promega is committed to excellence in technologies and compound profiling services to assess key processes in Targeted Protein Degradation and Induced Proximity mechanisms. From assessing protein degradation in real time, to understanding compound binding and permeability, to ternary complex formation and more. Our CRIPSR HiBiT content covers hundreds of pre-built targets. Novel software analysis tools allow for the determination of target protein degradation rates, DC50 potency values, recovery profiles and more.
ALPX
Innovation Partner
ALPX, an EMBL spin-off and French CRO, delivers fully transparent structural biology services to biotech and pharma companies. We provide accelerated and high-quality structural insights, enabling our partners to focus on optimizing their small molecule or biologic projects into promising lead candidates. With our cryo-EM and automated protein crystallography platforms, we offer a one-stop-shop solution for all structural biology needs.
WuXi AppTec
Exhibition Partner
WuXi AppTec is a full-service provider of open-access capabilities and technology that enables customers worldwide to advance discoveries in the health sciences and deliver treatment to those in need.
HYBRIGENICS SERVICES
Event Partner
Hybrigenics Services, with 25+ years of expertise in advanced Y2H technology, offers the Y2HChem screening platform to identify protein-protein interactions induced or stabilized by molecular glues or bifunctional molecules. Y2HChem screens are conducted on the entire proteome using one of our 135+ libraries or a newly developed human E3 ligases library, enabling the discovery of substrate-E3 ligase interactions. With over 600 customer publications, we are recognized as a trusted scientific partner in providing high-quality and reliable results.
PHARMARON
Event Partner
At Pharmaron, we're a leading contract research organisation known for our extensive laboratory services and expertise in Target Product Degradation (TPD). With advanced facilities and a dedicated team, we specialise in customised solutions for drug discovery and development. Our TPD capabilities allow for precise evaluation of drug stability and efficacy, ensuring the delivery of top-quality pharmaceuticals. With a track record of supporting over 2000 organisations globally, we've become a trusted partner in the biopharmaceutical field.
SAI Life Sciences Limited
Event Partner
As India’s fastest growing CRO-CDMO, Sai Life Sciences works with over 300 innovator biotech and pharma companies globally, to accelerate the discovery, development and commercialization of their small molecule programs. Sai’s Discovery services are designed to accelerate the journey from ‘Concept to Clinic’ through speed & high-quality data, bringing together medicinal chemistry, biology, DMPK, toxicology under one roof to fast-track the DMTA (Design, Make, Test and Analyze) cycle, across Oncology, CNS, Inflammation, Antivirals, Rare diseases, and more.
CATALENT
Event Partner
Catalent specializes in comprehensive early-phase drug development and analytical solutions. From preclinical candidate selection to Phase 1, Catalent offers tailored solutions to help get customers’ drugs to clinic faster. Using a rigorous, data-driven scientific approach, API-sparing techniques, and advanced bioavailability enhancement technologies within a global network, Catalent helps solve complex challenges to accelerate drug development.
BMG LABTECH
Event Partner
BMG LABTECH is a leading developer and manufacturer of microplate reader instrumentation, used in pharmaceutical and biotech industries, as well as in academic research.
With more than 35 years’ specialised experience, we actively develop innovative optical detection solutions to deliver the best performance for all microplate reader assays. BMG LABTECH instruments are built for longevity by design, and are supported by applications and service support to ensure our customers can advance their research with confidence.
SeraNovo
Event Partner
Beacon
Research Partner
Beacon accelerates drug development for leading pharma and biotech companies, empowering them to bring innovative therapeutics to market faster. By integrating proprietary ontologies with comprehensive life sciences data, our platform provides unparalleled insights into the drug and clinical trial landscape. From gene therapies to biologics and cell-based solutions, Beacon equips teams with the clarity and tools for confident, data-driven decisions. Trusted by global leaders, Beacon streamlines drug development, enabling breakthroughs in innovative treatments.